NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
8 hedge funds and large institutions have $1.07M invested in NeuroMetrix, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
22% less capital invested
Capital invested by funds: $1.37M → $1.07M (-$301K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$359K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$74.6K |
| 3 |
Goldman Sachs
New York
|
+$51.3K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.33K |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$4.66K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$72K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$51.3K |
| 3 |
Citigroup
New York
|
-$9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BIT
1
BlackRock Institutional Trust
San Francisco,
California
| $837K | +$74.6K | +16 | +10% |
|
|
NMC
2
NEA Management Company
Timonium,
Maryland
| $103K | – | – | – |
|
|
3
Goldman Sachs
New York
| $52K | +$51.3K | +11 | New |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $32K | +$9.33K | +2 | +40% |
|
|
VKH
5
Virtu KCG Holdings
New York
| $31K | -$51.3K | -11 | -61% |
|
|
U
6
UBS
Zurich,
Switzerland
| $6K | +$4.66K | +1 | New |
|
|
BA
7
BlackRock Advisors
Wilmington,
Delaware
| $4K | – | – | – |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $1K | – | – | – |
|
|
SM
9
Sabby Management
Miami Beach,
Florida
| $561 | +$359K | +77 | +171% |
|
|
TDC
10
Thompson Davis & Co
Richmond,
Virginia
| – | -$72K | -15 | Closed |
|
|
11
Citigroup
New York
| – | -$9K | -2 | Closed |
|
NURO Hedge Fund Activity: Q3 2014 in Review
8 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q3 2014, worth a combined $1.07M — down 22% from $1.37M a quarter earlier.
Fund positioning in NURO was balanced in Q3 2014: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Sabby Management, adding an estimated $359K. The largest seller was Thompson Davis & Co, exiting entirely with an estimated $72K sold.
- 8 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q3 2014, unchanged from Q2 2014.
- Funds reported $1.07M of NeuroMetrix, Inc. Common Stock stock for Q3 2014, down 22% quarter-over-quarter.
- 2 funds opened new NeuroMetrix, Inc. Common Stock positions in Q3 2014 and 2 closed out, a net change of 0 holders.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q3 2014 was Sabby Management, an estimated $359K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q3 2014 was Thompson Davis & Co, an estimated $72K sold.
Based on aggregated 13F filings for Q3 2014.